Chris Harbison

Chris Harbison is an experienced professional in the field of oncology clinical biomarkers, currently serving as Executive Director at Bristol Myers Squibb since October 2005. In this role, Chris leads programs and oversees late-stage assets in oncology biomarkers. Prior to this position, Chris held various roles including Director, Associate Director, Principal Scientist, and Senior Research Investigator at the Whitehead Institute from December 2004 to September 2005, as well as a post-doctoral associate role. Education credentials include a PhD in Biology from the Massachusetts Institute of Technology, obtained between 1998 and 2004, and an AB in Biology from Harvard University, from 1992 to 1996. Earlier education includes attendance at Christian Brothers Academy and Keyport Central School.